F Galateau-Salle
Overview
    Explore the profile of F Galateau-Salle including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              62
            
            
              Citations
              774
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Benzerdjeb N, Dartigues P, Kepenekian V, Damiola F, Sequeiros R, Galateau-Salle F, et al.
  
  
    ESMO Open
    . 2024 Jul;
          9(8):103644.
    
    PMID: 39059063
  
  
          Background: Mesothelioma is a rare and aggressive malignant neoplasm arising from mesothelial cells, which occasionally manifests recurrent fusions. EWSR1/FUS-CREB, YY1, MAP3K8, NR4A3, and ALK-rearranged proliferations have been reported in limited...
      
2.
        
    
    Alcala N, Leblay N, Gabriel A, Mangiante L, Hervas D, Giffon T, et al.
  
  
    Nat Commun
    . 2019 Aug;
          10(1):3407.
    
    PMID: 31431620
  
  
          The worldwide incidence of pulmonary carcinoids is increasing, but little is known about their molecular characteristics. Through machine learning and multi-omics factor analysis, we compare and contrast the genomic profiles...
      
3.
        
    
    Le Stang N, Bouvier V, Glehen O, Villeneuve L, Galateau-Salle F, Clin B
  
  
    Cancer Epidemiol
    . 2019 Apr;
          60:106-111.
    
    PMID: 30953970
  
  
          Background: Peritoneal malignant mesothelioma is a rare disease for which few population-based studies are available. The aim of this study was to describe the evolution of the incidence and survival...
      
4.
        
    
    Audemard-Verger A, Lepennec V, Galateau-Salle F, Verdon R
  
  
    Rev Mal Respir
    . 2016 Feb;
          33(3):264-6.
    
    PMID: 26857199
  
  
          No abstract available.
      
5.
        
    
    Bienvenu B, Ly K, Lambert M, Agard C, Andre M, Benhamou Y, et al.
  
  
    Rev Med Interne
    . 2016 Feb;
          37(3):154-65.
    
    PMID: 26833145
  
  
          Purpose: Management of giant cell arteritis (GCA, Horton's disease) involves many uncertainties. This work was undertaken to establish French recommendations for GCA management. Methods: Recommendations were developed by a multidisciplinary...
      
6.
        
    
    Deshayes S, Galateau-Salle F, de La Blanchardiere A
  
  
    Rev Med Interne
    . 2014 Jul;
          36(5):363-4.
    
    PMID: 25063545
  
  
          No abstract available.
      
7.
        
    
    Brugiere C, Karanian-Philippe M, Comoz F, Dompmartin A, Galateau-Salle F, Verneuil L
  
  
    Br J Dermatol
    . 2014 May;
          171(4):899-902.
    
    PMID: 24779866
  
  
          Mycosis fungoides (MF) is the most common type of primary cutaneous T-cell lymphoma (CTCL), and folliculotropic MF (FMF) is one clinical variant of classic MF. MF generally has a good...
      
8.
        
    
    Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, et al.
  
  
    Thorax
    . 2014 Feb;
          69(6):532-9.
    
    PMID: 24508707
  
  
          Objectives: To estimate the proportion of pleural mesothelioma cases that can be attributed to asbestos exposure in France including non-occupational exposure. Methods: A population-based case-control study including 437 incident cases...
      
9.
        
    
    Audemard A, Bienvenu B, Magnier R, Fournier L, Galateau-Salle F, Martin Silva N
  
  
    Arthritis Rheum
    . 2013 Aug;
          65(12):3303.
    
    PMID: 23983058
  
  
          No abstract available.
      
10.
        
    
    Tallet A, Nault J, Renier A, Hysi I, Galateau-Salle F, Cazes A, et al.
  
  
    Oncogene
    . 2013 Aug;
          33(28):3748-52.
    
    PMID: 23975423
  
  
          Malignant pleural mesothelioma (MPM) is a very aggressive tumor with no known curative treatment. Better knowledge of the molecular mechanisms of mesothelial carcinogenesis is required to develop new therapeutic strategies....